HomeRGC • NASDAQ
add
Regencell Bioscience Holdings Ltd
Previous close
$5.93
Day range
$5.50 - $6.44
Year range
$3.03 - $32.44
Market cap
73.07M USD
Avg Volume
45.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.16M | -32.59% |
Net income | -1.03M | 35.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.08M | 35.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.80M | — |
Total assets | 10.48M | -32.63% |
Total liabilities | 312.55K | -64.23% |
Total equity | 10.16M | — |
Shares outstanding | 13.01M | — |
Price to book | 7.60 | — |
Return on assets | -27.59% | — |
Return on capital | -28.44% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.03M | 35.97% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Website
Employees
12